Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was abruptly canceled.

After speculation as to whether this year’s flu vaccine could be poorly matched to the current strain of flu, new Centers for Disease Control and Prevention data released last week says otherwise. The 2024-25 influenza vaccine reduced the risk for influenza-associated outpatient visits and hospitalization,